WeGovy is intended for adults with a BMI of 30 or higher, or a BMI of 27 or higher with weight-related conditions such as high blood pressure, type 2 diabetes, or high cholesterol
A prevalence study [33] reported 12% severe visual loss in IIH within the UK
For the CASSCF(14,13) geometry optimization, one form of vitamin B12 and one of the dissociated flavonoid agent anions were placed approximately 4.5 apart, where no chemical interaction should occur
1,2 Despite advances in pharmacotherapy, unmet needs persist: many patients fail to meet glycemic or weight-loss targets, and existing agents like glucagon-like peptide-1 (GLP-1) receptor agonists (eg, semaglutide) are limited by tolerability issuesparticularly gastrointestinal 3 (GI) adverse events in ~44% of users, leading to 4.3% treatment discontinuation